Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3No longer available 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Sarcoma, Myeloid 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1High Risk Hematologic Malignancy 1Congenital Abnormalities 1

Interventions

Cyclophosphamide 12fludarabine 11fludarabine phosphate 8Tacrolimus 8Melphalan 8Whole-Body Irradiation 7Mycophenolic Acid 7Thiotepa 6Imatinib Mesylate 6nilotinib 5Granulocyte Colony-Stimulating Factor 5Dasatinib 5Busulfan 5venetoclax 4ponatinib 4asciminib 4Mesna 4bosutinib 3Sirolimus 3Peripheral Blood Stem Cell Transplantation 3thymoglobulin 2ruxolitinib 2blinatumomab 2Patient Reported Outcome Measures 2Filgrastim 2Antilymphocyte Serum 2selinexor 1plerixafor 1Triamcinolone 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Transplantation × Clear all
NCT02790515 2025-08-12

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
170 enrolled
LymphoidMyeloidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Sarcoma, Myeloid, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡